Enable Accessibility Enable Accessibility

Retail Investor Resource Hub 

Welcome to Takeda’s resource hub for retail investors. Here you can sign up for email alerts, stay up to date on financial results and corporate milestones, and learn how Takeda is delivering on our commitment to patients, our people, and the planet. 

Stay up to date on our covid-19 efforts, visit: www.takeda.com/covid-19-information-center


Please wait...

Please wait...



Takeda Highlights

Guided by our values and our commitment to Patients, People and Planet, Takeda is delivering on its financial commitments, including the strategic allocation of capital  to growth drivers, debt reduction, and shareholder returns.

We make disciplined and focused investments in value-creating business opportunities including R&D, new product launches, including in China, and plasma-derived therapies, and have committed to maintaining solid investment grade credit ratings. In respect of "Shareholder returns", Takeda has maintained its well-established dividend policy of 180 yen per share annually.

Our Internal R&D Engine and External Collaborations

We leverage our own research Capabilities, while also acitively engaging with innovative ecosystems around the world to translate science into highly transformative or curative potential medicines for targeted populations with a high unmet need

R&D Investment

text content

test under


Biopharmaceutical company

with presence in approx.80 countries and regions

R&D Investment

text content

As of March 2021. References: FY2020 Q4 Investor Presentation; Corporate Overview 

1USD included for reference, calculated at JPY/USD of 110.6 

2Non-IFRS measure.  Further information on this and other Takeda Non-IFRS measures is posted on Takeda’s investor relations website 



AGM 2021

Visit our dedicated page for the 145th Ordinary General Meeting of Shareholders




Investor Events



Sustainability Report

Learn how we’re helping to solve key societal challenges and creating value for society by using our core strengths and capabilities





ESG at Takeda

Frequently Asked Questions

General Information

Our 2021 Ordinary General Meeting of Shareholders is currently scheduled for June 29, 2021. Please visit our Annual Shareholders Meeting page for more information.


Stock Information

You may contact a licensed stockbroker or go through any registered broker-dealer to purchase shares of Takeda.

Takeda’s common shares are listed on the Tokyo Stock Exchange and trades using stock code “4502.” Our ADSs are traded on the New York Stock Exchange  using the symbol “TAK”. 

An American Depositary Receipt (ADR) is a certificate representing ownership of American Depositary Shares (ADSs) in a non-U.S. corporation. They include the right to vote at and attend AGMs, the receipt of dividends, and other common shareholder rights. One ADS represents 0.5 shares of Takeda’s common stock.  

Click here to learn more about Takeda’s historic share price performance.

Takeda’s largest shareholders and other share data, as most recently reported, can be found here. 


Dividend Information

Takeda has maintained a well-established dividend policy of 180 yen per share annually.  

Takeda’s  dividend payments have historically been issued on a semi-annual basis in June and December.  


Financial Information

Takeda’s fiscal year ends on March 31st. You can find our earnings materials and dates on our financial results webpage.

Takeda’s official reporting currency is the yen.

Takeda follows the International Financial Reporting Standards, or IFRS, for its financial reporting.

For historic financial highlights of Takeda, please refer to our Financial Highlights page.


Additional Information

To send a comment or question to Takeda Pharmaceutical Company Limited, please visit: https://www.takeda.com/who-we-are/contact-us/

To subscribe to email alerts from Takeda, please use the form at the top of this page.


For feedback or inquiries, please visit https://www.takeda.com/who-we-are/contact-us/

Select the alerts you’d like to receive: * Indicates required field

At least one alert must be selected

Select one of the following:

Takeda will use the contact information you entered above to provide you with the investor related materials you requested. For more information on how Takeda processes your personal data and you rights related to this processing, please refer to our Privacy Notice.